Recent discussions on X about Procter & Gamble (PG) have centered around the company’s latest quarterly earnings report, which showed a solid earnings beat with adjusted EPS of $1.48, up 5.71% year-over-year, and revenue of $20.889 billion, reflecting a 1.74% increase. Many users highlighted the resilience of the consumer goods giant, pointing to its ability to navigate challenges like tariff headwinds while maintaining in-line guidance for the upcoming fiscal year. The conversation also touched on a massive cost-cutting plan unveiled by the company, sparking curiosity about future profitability.
However, not all feedback was overwhelmingly positive, as some noted a slight stock price dip of 0.3% following the earnings release, attributed to forecasts of annual results falling below estimates and planned price hikes to offset tariffs. There’s a palpable tension in the discussions, with some expressing concern over potential consumer pushback on price increases for everyday products like dish soap and toilet paper. Overall, the dialogue reflects a mix of optimism for PG’s strategic moves and caution regarding external economic pressures.
Note: This discussion summary was generated from an AI condensation of post data.
Procter & Gamble Congressional Stock Trading
Members of Congress have traded $PG stock 13 times in the past 6 months. Of those trades, 5 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $PG stock by members of Congress over the last 6 months:
- REPRESENTATIVE SCOTT FRANKLIN sold up to $50,000 on 06/16.
- REPRESENTATIVE CLIFF BENTZ purchased up to $15,000 on 06/06.
- REPRESENTATIVE LLOYD DOGGETT has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/15, 02/18 and 0 sales.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 0 purchases and 2 sales worth up to $200,000 on 05/12, 02/24.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 3 times. They made 1 purchase worth up to $15,000 on 03/03 and 2 sales worth up to $30,000 on 04/21, 03/20.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
- REPRESENTATIVE GREG LANDSMAN sold up to $50,000 on 03/27.
- REPRESENTATIVE GEORGE WHITESIDES sold up to $250,000 on 03/24.
- REPRESENTATIVE DAVID TAYLOR purchased up to $15,000 on 02/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Procter & Gamble Insider Trading Activity
Procter & Gamble insiders have traded $PG stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $PG stock by insiders over the last 6 months:
- GARY A COOMBE (CEO - Grooming) has made 0 purchases and 2 sales selling 53,000 shares for an estimated $9,168,533.
- MOSES VICTOR JAVIER AGUILAR (Chf Rsch, Dev & Innov Officer) sold 10,520 shares for an estimated $1,669,199
- JENNIFER L. DAVIS (CEO - Health Care) sold 1,000 shares for an estimated $161,384
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Procter & Gamble Hedge Fund Activity
We have seen 1,723 institutional investors add shares of Procter & Gamble stock to their portfolio, and 1,872 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 76,017,350 shares (+655209.0%) to their portfolio in Q2 2025, for an estimated $12,111,084,202
- GAMMA INVESTING LLC removed 7,903,889 shares (-99.4%) from their portfolio in Q2 2025, for an estimated $1,259,247,595
- FISHER ASSET MANAGEMENT, LLC removed 7,260,396 shares (-38.8%) from their portfolio in Q1 2025, for an estimated $1,237,316,686
- BANK OF AMERICA CORP /DE/ added 3,979,298 shares (+13.1%) to their portfolio in Q1 2025, for an estimated $678,151,965
- CANADA PENSION PLAN INVESTMENT BOARD removed 3,107,680 shares (-70.2%) from their portfolio in Q1 2025, for an estimated $529,610,825
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,466,308 shares (+13.0%) to their portfolio in Q1 2025, for an estimated $420,308,209
- JPMORGAN CHASE & CO added 2,249,683 shares (+9.3%) to their portfolio in Q1 2025, for an estimated $383,390,976
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Procter & Gamble Analyst Ratings
Wall Street analysts have issued reports on $PG in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 07/30/2025
- UBS issued a "Buy" rating on 07/17/2025
- B of A Securities issued a "Buy" rating on 04/25/2025
- Citigroup issued a "Buy" rating on 04/25/2025
- Morgan Stanley issued a "Overweight" rating on 04/25/2025
- Raymond James issued a "Outperform" rating on 04/25/2025
- Truist Securities issued a "Buy" rating on 04/25/2025
To track analyst ratings and price targets for Procter & Gamble, check out Quiver Quantitative's $PG forecast page.
Procter & Gamble Price Targets
Multiple analysts have issued price targets for $PG recently. We have seen 12 analysts offer price targets for $PG in the last 6 months, with a median target of $178.5.
Here are some recent targets:
- Lauren Lieberman from Barclays set a target price of $164.0 on 07/31/2025
- Chris Carey from Wells Fargo set a target price of $173.0 on 07/30/2025
- Andrea Teixeira from JP Morgan set a target price of $170.0 on 07/25/2025
- Peter Grom from UBS set a target price of $180.0 on 07/17/2025
- Robert Ottenstein from Evercore ISI Group set a target price of $170.0 on 07/14/2025
- Korinne Wolfmeyer from Piper Sandler set a target price of $164.0 on 05/05/2025
- Olivia Tong from B of A Securities set a target price of $180.0 on 04/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
